RRP43 antibodies are immunological reagents targeting the RRP43 protein (UniProt ID: Q96B26 in humans), a core subunit of the RNA exosome complex. These antibodies are widely used in:
Western blotting: Detects RRP43 at ~34 kDa in human HEK-293T and HeLa cell lysates .
Immunoprecipitation: Identifies protein-protein interactions, such as RRP43's binding to Rrp46p in yeast .
Immunofluorescence: Localizes RRP43 to the nucleolus, nucleoplasm, and cytoplasm .
RRP43 is essential for:
RNA degradation: Facilitates 3'-5' exoribonuclease activity in the nuclear and cytoplasmic exosome .
Pre-rRNA processing: Required for 5.8S rRNA maturation and 27S pre-rRNA cleavage in Saccharomyces cerevisiae .
mRNA stability: Depletion in yeast (rrp43-ts mutants) increases mRNA half-lives (e.g., ACT1 mRNA from 20 to 40 minutes) .
Central region (aa 162–276): Critical for thermostability and exosome interactions. Mutations here (e.g., Val212Ala, Ser162Phe) impair RNA processing .
RNase PH-like domain: Shares homology with bacterial RNase PH but lacks direct catalytic activity .
Temperature-sensitive mutants (rrp43-1, rrp43-2, rrp43-3):
Interaction network: Rrp43p binds Rrp46p, forming a structural node essential for exosome integrity .
Neurodegeneration: EXOSC8 (human RRP43) mutations disrupt mitochondrial RNA metabolism, leading to oxidative phosphorylation defects .
Cancer: Dysregulated exosome activity alters mRNA stability, potentially influencing oncogene expression .
KEGG: sce:YCR035C
STRING: 4932.YCR035C
RRP43 (Ribosomal RNA Processing protein 43) is an essential subunit of the exosome complex involved in RNA processing and degradation pathways. In Saccharomyces cerevisiae, Rrp43p has been identified as a component of the exosome through co-purification studies with ProtA-Rrp4p . This protein participates in both pre-rRNA processing and mRNA degradation, making it crucial for multiple aspects of RNA metabolism.
Functionally, Rrp43p shows sequence similarity to Escherichia coli RNase PH, suggesting a potential role in phosphorolytic RNA degradation, though direct RNase activity has not been demonstrated for Rrp43p itself . Studies with temperature-sensitive mutants have confirmed that Rrp43p is required for proper mRNA decay in yeast, as evidenced by extended mRNA half-lives and accumulation of degradation intermediates in mutant strains .
Subcellular localization studies have detected Rrp43p in multiple cellular compartments including the nucleolus, nucleoplasm, and cytoplasm . This broad distribution reflects its diverse functions in RNA metabolism. While the nucleolar and nuclear fractions of Rrp43p primarily function in pre-rRNA processing and degradation of excised spacer sequences, the cytoplasmic fraction is involved in mRNA degradation pathways .
When selecting antibodies for RRP43 detection, researchers should consider this multi-compartmental distribution. Antibodies that recognize epitopes that remain accessible in different cellular environments and under various experimental conditions (such as different fixation methods) are preferable. For compartment-specific studies, researchers should validate the antibody's specificity in subcellular fractionation experiments followed by western blotting.
The primary experimental model for studying RRP43 function has been Saccharomyces cerevisiae. Several specialized yeast strains have been developed for this purpose, as shown in the table below:
| Strain | Relevant characteristics | Primary application |
|---|---|---|
| DG458 | rrp43::KAN with GAL-regulated ProtA::RRP43 | Controlled expression studies |
| YCO44 | Wild-type RRP43 control strain | Baseline comparison |
| rrp43-1 | Temperature-sensitive mutant | mRNA decay/pre-rRNA processing studies |
| rrp43-2 | Temperature-sensitive mutant | mRNA decay/pre-rRNA processing studies |
| rrp43-3 | Temperature-sensitive mutant | mRNA decay/pre-rRNA processing studies |
| L40-based strains | Two-hybrid system hosts | Protein-protein interaction studies |
These experimental models, particularly the temperature-sensitive mutants (rrp43-1, rrp43-2, and rrp43-3), have been invaluable for dissecting RRP43's role in RNA metabolism under controlled conditions .
RRP43 antibodies can be employed in co-immunoprecipitation (co-IP) experiments to investigate interactions within the exosome complex. Two-hybrid analyses have revealed that Rrp43p interacts with the exosome complex primarily through Rrp46p . This specific interaction provides a crucial point for antibody-based studies.
When designing co-IP experiments with RRP43 antibodies, researchers should consider:
Using mild lysis conditions to preserve native protein complexes
Including appropriate controls to verify specificity (such as IgG controls)
Performing reciprocal IPs with antibodies against suspected interacting partners
Validating results with alternative methods such as proximity ligation assays
Based on two-hybrid analyses, researchers should expect to co-precipitate Rrp46p strongly, while other exosome subunits may be detected as part of the larger complex rather than through direct interaction with Rrp43p .
RRP43 antibodies can be instrumental in elucidating mRNA degradation pathways, particularly when used in combination with temperature-sensitive mutant strains. Research has shown that rrp43 temperature-sensitive mutants exhibit significantly extended mRNA half-lives compared to wild-type strains, as shown in the following data:
| mRNA | Wild-type half-life (min) | rrp43-1 half-life (min) | rrp43-2 half-life (min) | rrp43-3 half-life (min) |
|---|---|---|---|---|
| ACT1 | 20 | ~40 | 32 | ~40 |
| CATpG | 37 | 52 | 65 | 62 |
Studies with the CATpG reporter mRNA, which contains a poly(G) segment that impairs 5'→3' degradation, revealed that rrp43 mutants accumulate a degradation intermediate corresponding to the poly(G) fragment . This finding suggests that Rrp43p functions in the 3'→5' mRNA decay pathway.
By using RRP43 antibodies to deplete the protein or to analyze its association with specific mRNAs (through techniques like RNA immunoprecipitation), researchers can further dissect its role in various decay pathways.
Mutations in RRP43 lead to specific defects in pre-rRNA processing, which can be analyzed using RRP43 antibodies in conjunction with RNA analysis techniques. In temperature-sensitive rrp43 mutants, the following pre-rRNA processing defects have been observed:
Accumulation of aberrant 23S pre-rRNA
Defects in 27S pre-rRNA processing
Reduced formation of 20S pre-rRNA
Interestingly, different rrp43 mutant alleles can show distinct phenotypes. For example, in strain rrp43-3, 20S pre-rRNA levels decrease after prolonged incubation at restrictive temperature without a corresponding increase in 23S pre-rRNA, suggesting possible destabilization of 20S pre-rRNA. In contrast, strain rrp43-2 shows a higher 23S:20S ratio due to increased aberrant 23S pre-rRNA concentration .
For comprehensive analysis, researchers should combine:
Northern blot analysis of steady-state RNA levels
Pulse-chase labeling with [methyl-³H]methionine
RNA immunoprecipitation with RRP43 antibodies to identify associated pre-rRNAs
Proper validation of RRP43 antibodies is essential for reliable experimental results. The following protocol is recommended for comprehensive validation:
Specificity testing: Compare immunoblotting results between wild-type strains and rrp43 deletion strains complemented with plasmid-borne RRP43 (e.g., strain DG458) .
Epitope accessibility assessment: Test antibody performance in different subcellular fractions since Rrp43p is present in multiple compartments.
Cross-reactivity evaluation: Test against strains expressing epitope-tagged versions of RRP43 (such as HA-RRP43) to confirm specific recognition .
Functional validation: Confirm that antibody binding doesn't interfere with RRP43 function by performing immunoprecipitation followed by functional assays of the precipitated complex.
Immunodepletion controls: Perform sequential immunoprecipitations to confirm complete depletion of the target protein.
Including appropriate controls is critical - wild-type strains, deletion mutants, and strains expressing tagged versions of RRP43 (as shown in the plasmid table below) provide essential reference points.
| Plasmid | Relevant characteristics | Validation application |
|---|---|---|
| pCFUS-HARRP43 | MET25::HA-RRP43, CEN6, URA3 | Positive control for epitope-tagged RRP43 |
| pCFUS-HArrp43-1 | MET25::HA-rrp43-1, URA3, CEN6 | Mutant control for specificity testing |
| pCFUS-HArrp43-2 | MET25::HA-rrp43-2, URA3, CEN6 | Mutant control for specificity testing |
| pCFUS-HArrp43-3 | MET25::HA-rrp43-3, URA3, CEN6 | Mutant control for specificity testing |
RNA immunoprecipitation (RIP) using RRP43 antibodies can reveal the RNA species associated with RRP43 in vivo. The following protocol is optimized for this application:
Cell preparation:
Harvest yeast cells during logarithmic growth phase
Crosslink with 1% formaldehyde for 10 minutes at room temperature if studying transient interactions
Prepare cell lysates using a buffer containing 50 mM HEPES pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, and RNase inhibitors
Immunoprecipitation:
Pre-clear lysate with Protein A/G beads for 1 hour at 4°C
Incubate pre-cleared lysate with RRP43 antibody overnight at 4°C
Add fresh Protein A/G beads and incubate for 2-3 hours at 4°C
Wash extensively with lysis buffer followed by higher stringency washes
RNA recovery and analysis:
Reverse crosslinks if applicable (65°C for 1 hour in presence of proteinase K)
Extract RNA using phenol-chloroform method
Analyze by northern blotting, qRT-PCR, or RNA sequencing
This protocol is particularly effective for studying RRP43's association with pre-rRNAs and mRNAs undergoing degradation. For temperature-sensitive mutants, perform the procedure after shifting to non-permissive temperature for 2-4 hours to observe changes in RNA association patterns .
Distinguishing between the nuclear and cytoplasmic functions of RRP43 requires specialized antibody-based approaches that focus on spatial separation and functional analysis:
Subcellular fractionation combined with immunoblotting:
Prepare nuclear, nucleolar, and cytoplasmic fractions using established protocols
Perform western blotting with RRP43 antibodies on each fraction
Include compartment-specific markers (e.g., histone H3 for nucleus, α-tubulin for cytoplasm)
Quantify relative RRP43 levels in each compartment
Immunofluorescence microscopy with co-localization analysis:
Fix cells using methods that preserve nuclear architecture (e.g., 4% paraformaldehyde)
Perform immunofluorescence using RRP43 antibodies alongside compartment markers
Conduct quantitative co-localization analysis
Compare wild-type localization patterns with those in mutant strains
Compartment-specific functional assays:
Nuclear function: Analyze pre-rRNA processing defects after nuclear depletion
Cytoplasmic function: Monitor mRNA decay rates after cytoplasmic depletion
Compare results with those from temperature-sensitive mutants to identify compartment-specific phenotypes
The most effective approach combines these methods with genetic strategies, such as using mutants with altered nuclear/cytoplasmic distribution or mutations that specifically affect one compartment's functions while preserving the other's.
Successful western blotting with RRP43 antibodies requires attention to several critical parameters:
Sample preparation:
Use fresh cell lysates prepared with protease inhibitors
For yeast samples, glass bead lysis in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 is effective
Include both denatured total cell lysates and native immunoprecipitated samples for comparison
Electrophoresis conditions:
Transfer and detection optimization:
PVDF membranes with 0.45 μm pore size are recommended
Block with 5% non-fat dry milk in TBST
Primary antibody dilutions of 1:1000-1:5000 are typically effective
Include both chemiluminescent detection and fluorescent secondary antibodies for quantitative analysis
Validation controls:
Include wild-type, deletion mutant complemented with plasmid-borne RRP43, and epitope-tagged strains
For mutant analysis, compare samples before and after temperature shift
By optimizing these parameters, researchers can achieve reliable and reproducible detection of RRP43 in various experimental contexts.
To effectively analyze protein-protein interactions within the exosome complex using RRP43 antibodies, researchers should implement a multi-faceted approach:
Sequential co-immunoprecipitation:
Perform initial IP with RRP43 antibody
Elute under mild conditions
Conduct second IP with antibodies against other exosome components
This approach can confirm direct interactions versus indirect complex associations
Crosslinking immunoprecipitation:
Proximity-based interaction analysis:
Employ techniques such as proximity ligation assay (PLA)
Combine RRP43 antibodies with antibodies against other exosome components
Quantify interaction signals in different cellular compartments
Competitive binding assays:
Use recombinant or purified exosome components to compete with native interactions
Assess how these competitors affect RRP43 antibody precipitation of the complex
This approach can help map the interaction surface
Based on two-hybrid analyses, researchers should focus particularly on the RRP43-RRP46 interaction, as this appears to be the primary connection between RRP43 and the rest of the exosome complex .
Researchers frequently encounter several challenges when performing immunoprecipitation with RRP43 antibodies. Here are the most common issues and their solutions:
Low IP efficiency:
Problem: Insufficient recovery of RRP43 protein
Solutions:
Loss of protein interactions:
Problem: Failure to co-precipitate known interactors like Rrp46p
Solutions:
Use milder lysis and wash buffers
Reduce wash stringency while maintaining specificity
Include stabilizing agents like glycerol (5-10%) in buffers
Consider chemical crosslinking to preserve interactions
High background:
Problem: Non-specific protein binding obscuring results
Solutions:
Increase pre-clearing time with beads alone
Add competing proteins (BSA) to blocking and wash buffers
Use more stringent washes for final wash steps
Include appropriate IgG controls
Inconsistent results between replicates:
Problem: Variable recovery of RRP43 and interacting partners
Solutions:
Standardize cell growth conditions and lysis procedures
Prepare fresh buffers for each experiment
Quantify protein content before IP to ensure consistent input
Consider automated IP methods for greater reproducibility
When troubleshooting, it's advisable to first test antibodies with epitope-tagged versions of RRP43 (such as those expressed from pCFUS-HARRP43) to establish baseline performance before proceeding to endogenous protein detection.
When researchers encounter discrepancies between results obtained with RRP43 antibodies and genetic approaches, careful interpretation and validation are essential:
Analyze antibody specificity comprehensively:
Verify antibody recognition using both wild-type and mutant strains
Confirm specificity with epitope-tagged versions and genetic knockouts
Consider whether the antibody might recognize specific conformations or post-translational modifications
Evaluate functional relevance of interactions:
Consider technical limitations of different approaches:
Reconcile conflicting data methodically:
Design experiments that directly address the discrepancy
Employ orthogonal techniques (e.g., BioID, APEX proximity labeling)
Consider whether tissue/cell-type specific or condition-dependent factors may explain differences
The temperature-sensitive RRP43 mutants provide an excellent system for validating antibody results. For instance, if these mutants disrupt interaction with Rrp46p as shown by two-hybrid analysis , antibody-based co-immunoprecipitation should confirm this disruption under non-permissive conditions.
By systematically addressing these considerations, researchers can resolve discrepancies and develop a more complete understanding of RRP43 function within the exosome complex.